sermorelin acetate: Frequently asked questions

Cloudiness indicates peptide aggregation, bacterial contamination, or the presence of particulate matter from improper lyophilisation. Do not use it. Pharmaceutical-grade sermorelin acetate should produce a perfectly clear, colourless solution within 30–60 seconds of adding bacteriostatic water. If cloudiness persists after gentle swirling (never shake peptide vials. Shearing forces denature peptides), the vial is compromised. Temperature excursions during shipping. Particularly exposure to >25°C for extended periods. Can cause partial denaturation even in acetate-stabilised peptides, leading to aggregation upon reconstitution. This is why cold chain integrity matters more than the peptide's intrinsic stability.

Sermorelin base (free-base peptide without a counterion) is not a standard pharmaceutical preparation and should be treated as a red flag unless the supplier provides explicit documentation of stability testing and proper storage protocols. The lower price likely reflects reduced manufacturing cost due to skipped acetylation steps or lack of quality control during lyophilisation. Free-base peptides are used in some research contexts where immediate reconstitution and use is planned, but for any application requiring storage beyond 48 hours, the acetate salt is the only reliable form.

Request a certificate of analysis from the supplier before reconstituting. A legitimate CoA will specify the salt form used, report peptide purity by HPLC, and state the net peptide content excluding counterion weight. If the supplier cannot provide this documentation, the preparation is not pharmaceutical-grade and may contain unknown counterions, residual solvents from synthesis, or aggregated peptide that won't dissolve properly. The absence of 'acetate' in the product name doesn't automatically indicate inferior quality. Some suppliers use 'sermorelin' as shorthand when acetate is the implied default. But the CoA must confirm the salt form explicitly.

It's still sermorelin acetate. The acetate salt is required for lyophilization. Vendors sometimes drop 'acetate' from labels to simplify branding, but the chemical structure is identical. What you should verify instead: HPLC purity certificates (target >98%), third-party endotoxin testing, and sterile manufacturing conditions. A vendor omitting 'acetate' isn't hiding anything. It's assumed in every lyophilized peptide preparation.

Lyophilized sermorelin acetate tolerates short-term ambient temperature (up to 25°C for 48–72 hours) without significant degradation. If the vial was in transit for fewer than three days and wasn't exposed to direct heat, it's likely fine. Once received, store it immediately at -20°C. The risk isn't the peptide denaturing instantly. It's cumulative exposure reducing potency over time. If you're uncertain about cold-chain integrity, request a replacement or ask the supplier for stability data on their shipping method.

Sterile water works for single-use reconstitution, but bacteriostatic water (0.9% benzyl alcohol) prevents bacterial growth during multi-dose storage. If you reconstitute with sterile water, you must use the entire vial within 24 hours and store it at 2–8°C. Bacteriostatic water extends the reconstituted peptide's usable life to 28 days under refrigeration. For research protocols requiring repeated dosing, bacteriostatic water is non-negotiable. Sterile water creates contamination risk after the first puncture.

Both are likely correct but referencing different components of the same compound. A listing showing 3,213 Da refers to the sermorelin peptide chain alone (29 amino acids, no counterion). A listing showing 3,357.96 Da includes the acetate salt mass. Neither changes the functional dose: a 2mg vial contains 2mg of total sermorelin acetate, and the acetate contributes negligible weight to dosing calculations. When comparing products, ignore molecular weight discrepancies and focus on purity percentage, endotoxin levels, and whether the supplier provides full HPLC and mass spec data. The acetate designation doesn't affect potency. Sequence fidelity and storage integrity do.

Persistent cloudiness, visible particulates, or undissolved fragments indicate peptide degradation. Not a formulation error. Sermorelin acetate manufactured and stored correctly dissolves into a clear, colourless solution within 60 seconds of adding bacteriostatic water. Aggregation results from temperature excursions (storage above −20°C before reconstitution, or shipping without cold packs), moisture contamination in the vial, or synthesis errors that produced misfolded peptide chains. Do not use cloudy sermorelin. Aggregated peptides are biologically inactive and introduce variability into experimental results. Contact the supplier for a replacement and request temperature logging data for the shipment. Reputable vendors replace degraded batches immediately because they know proper cold-chain handling prevents this failure mode entirely.

No. All sermorelin used in research contexts is sermorelin acetate. Vendors omitting 'acetate' from the product name are simplifying nomenclature, not offering a distinct compound. Request the certificate of analysis: it will confirm molecular weight around 3,358 Da (sermorelin acetate) rather than 3,213 Da (free peptide, which isn't commercially produced in stable form). If the COA lists 'sermorelin acetate' but the product page says 'sermorelin', you're receiving the same peptide. The acetate isn't optional. It's structurally necessary for producing a shelf-stable lyophilised product that reconstitutes reliably.